Popularity of Consumer Driven Plans Increasing
Staff Writers
Filed under: Health Insurance | Tagged: High Deductible-HCPs | 7 Comments »
Popularity of Consumer Driven Plans Increasing
Staff Writers
Filed under: Health Insurance | Tagged: High Deductible-HCPs | 7 Comments »
New CMS Report for 2008
[By Staff Writers]
According to a new CMS report, national health spending grew 6.7% last year, reaching $2.2 trillion overall. But, it is expected to hold steady over the next 10 years.
Nevertheless, healthcare spending will account for 20% of GDP by 2017; if left unchecked.
Of course, more than a few health economists note that eliminating some Medicaid payment restrictions spiked hospital spending, but the sector is expected to see more growth in later years.
Fueling Medicare growth dramatically will be baby boomers as they become eligible. Medicare spending is expected to reach $427.3 billion in 2007, ballooning to more than twice that amount, or $884 billion, in 2017, according to some CMS estimates [about 7.2% annually].
***
***
Assessment
And so, what are your thoughts on this new report? Is this increase in GDP such a bad thing?
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
Filed under: Healthcare Finance | Tagged: Health Economics | 2 Comments »
Doctors Must Understand the Unique Risks
[By Julia O’Neal; MA, CPA]
Real Estate [RE] requires a separate discussion of unique risks relative to other financial asset classes.
Macro Economic and Other Risks
RE investments possess not only the macro-economic risks found in all financial assets, but other unique risks, as well.
For example, these risks include illiquidity, lack of a continuous auction trading market, and quoted prices that may or may not represent intrinsic value.
Lack of Diversification
Given the large size of many real estate projects, it may also be difficult to diversify adequately and reduce total portfolio risk.
And, because of the chance of segmented markets, the risk of imperfect information is also present.
Assessment
Remember, real estate is not easily divisible and is nonhomogeneous; such risks cannot be fully negated through diversification.
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
DICTIONARIES: http://www.springerpub.com/Search/marcinko
PHYSICIANS: www.MedicalBusinessAdvisors.com
PRACTICES: www.BusinessofMedicalPractice.com
HOSPITALS: http://www.crcpress.com/product/isbn/9781466558731
CLINICS: http://www.crcpress.com/product/isbn/9781439879900
BLOG: www.MedicalExecutivePost.com
FINANCE: Financial Planning for Physicians and Advisors
INSURANCE: Risk Management and Insurance Strategies for Physicians and Advisors
Filed under: Alternative Investments | Tagged: Investing Basics | 3 Comments »
Understanding PHOs
[By Dr. David Edward Marcinko; MBA CMP™]
A Physician Hospital Organization, or PHO, is a blend of private doctors and hospitals, maintaining its concentration and control of surgical, rather than medical care.
Ownership may be divided by a governing board, according to a pro-rata basis with the larger partner having most organizational strength and bargaining power in the corporate structure. Typically, this favors the hospital.
From a strategic standpoint, most MD’s are still not currently aligned with many PHO’s, since surgical care is increasing being delivered in private offices, Surgical Specialty Hospitals (SSHs) or Ambulatory Care Centers (ACCs).
Additionally, PHOs may become potential MD competitors, and may often lack managed care contracting experience, have inflexible provider networks and may require MD exclusivity in their organization.
PHO Functions
Nevertheless, the function of a PHO is to:
Assessment
Many believe the “p” in PHO should be lower-case; while an upper-case “H” is a sign of relative strength [i.e., pHO]. And so, what do you think?
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
Filed under: Book Reviews, Managed Care | Tagged: Health Economics | 22 Comments »
EXCLUSIVE MARCH SPECIAL REPORT!
A very special report on dentists – their professional practice career and economic life cycle – by a leading national dental management corporate executive.
AUTHOR: Thomas A. Knox MBA was senior vice-president for provider partnerships at Delta Dental Plan of Minnesota, which owns a major interest in a privately held dental practice management corporation [DPMC].
POSITION: Mr. Knox held senior leadership positions in several health care organizations for more than twenty-five years. He implemented various joint ventures, partnerships and business alliances in a variety of medical organizations. He is recently retired.
TOPIC: “Practice Management and Financial Planning: It’s [NOT] for Dentist’s Only”
EXERPT: “The challenge is that for many dentists their practice is too big and too profitable to sell to new dentists who have been, traditionally, the practice buyers. Almost fifty percent of present day dentists are baby boomers pushing 50-55 years of age. And unfortunately, they cannot afford to retire at this point and still maintain the lifestyle they have created. But, the temptation is there – the thought is occurring more frequently – and it is very compelling and very frustrating.”
Don’t miss it!
REQUEST IT NOW: Complimentary by email.
https://medicalexecutivepost.com/wp-content/uploads/2008/03/ddspracticelifecyclefinplanning.pdf
Filed under: Monthly Reports | Tagged: Dentists [DDS/DMD] | 2 Comments »
Understanding Industry Risk
By Julia O’Neal; MA, CPA
Often also called industry risk, sector risk is the risk of doing better or worse than expected as a result of investment in one sector of the economy instead of another.
Economic Classifications
A typical economic classification includes capital goods, consumer durables, consumer nondurables, financial, energy, utility, basic materials, technology, retail, and service. There are many more; of course.
Conclusion
Which sectors do you invest in, and do you appreciate the associated industry risks?
More info: http://www.springerpub.com/prod.aspx?prod_id=23759
Individual: http://www.jbpub.com/catalog/0763745790/
Institutional: www.HealthcareFinancials.com
Terms: www.HealthDictionarySeries.com
Filed under: Investing | Tagged: Investing Basics | Leave a comment »
A “Need-to-Know “ Glossary for all Medical Professionals
Staff Writers
Absolute volatility: The true volatility of an investment.
Accumulation phase: A phase in an investor’s life when he or she is trying to accumulate an estate; usually characterized by growth-oriented investments.
Alpha factor: Measures the residual non-market influences that contribute to a securities risk unique to each security.
Arithmetic mean: The sum of a set of numbers divided by the number of numbers in the set.
Capital appreciation: The growth of an investment’s principal.
Capital asset pricing model (CAPM): A model that uses beta and market return to help investors evaluate risk return trade-offs in investment decisions.
Capital Market Line: Represents a spectrum of two-asset portfolios, moving from a portfolio invested in 100% of the least risky asset to a portfolio invested in 100% of the most risky one. The Capital Market Line is plotted on a graph with % return plotted on the Y-axis and risk (standard deviation) plotted on the X-axis.
Co-movement: The degree to which an asset moves with other assets.
Consolidation phase: A phase in an investor’s life when he or she generally shifts assets to more conservative or stable investments with the hope of preventing any major losses to accumulated assets. The investor is still interested in the growth of the investments.
Covariance: The volatility of investments in relation to other investments.
Current income: Income received from investments.
Discount rate: The annual rate of return that could be earned currently on a similar investment; used when finding present value or opportunity cost.
Earnings momentum investing: A style of investing that looks for companies that are on growth trends similar to a growth style. Two nuances differentiate these two styles: (1) the earnings momentum style focuses mainly on the growth of the earnings of the company and (2) the earnings momentum style looks for an accelerating increase in the growth of earnings.
Efficient frontier: A line that represents the highest return for each particular mix of assets in a portfolio.
Geometric mean: The Nth root of the product of “n” numbers.
Growth investing: A style of investing that tries to outperform the market by investing in companies that are experiencing growth patterns in earnings, cash flows, sales, capitalization, etc.
Market timing: Trying to predict the gains and declines of the market and then buying at market lows and selling at market highs.
Mean rate of return: The return that is between two extreme returns.
Modern portfolio theory: An approach to portfolio management that uses statistical measures to develop a portfolio plan.
Negatively correlated: Two securities that move in opposite directions.
Nominal return: The return that an investment produces.
Periodic re-balancing: The act of shifting capital from asset classes that performed well to those that did not, in order to maintain a set ratio between asset classes.
Positively correlated: Two securities that move in the same direction.
Probability distribution: A statistical tool used to show the dispersion around an expected result.
Real return: The actual return after factors such as inflation and taxes are taken into consideration.
Realized gain or loss: Gain or loss experienced by an investor during a period.
Regression analysis: A statistical tool used to measure the relationship between two or more variables.
Relative efficiency: The belief that the markets reflect current information in their prices.
Risk-averse: Describes a physician investor who requires greater return in exchange for taking on greater risk.
Sector rotation investing: A style of investing in which the goal is to out-perform the market by investing more heavily in the sectors that are forecasted to perform better than the market in expected economic scenarios.
Spending phase: The phase in an investor’s life when he or she is living on accumulated assets; generally characterized by a portfolio invested mainly in income-oriented investments, although a portion of growth is usually maintained.
Standard deviation: A statistical method used to measure the dispersion around an asset’s average or expected return and the most common single indicator of an asset’s risk.
Unrealized gain or loss: A gain or loss on paper that is not realized until the investment is sold.
Value investing: A style of investing that searches for undervalued companies and buys their stock in hopes of sharing in the future gain when other analysts discover the company.
Yield curve: A graph that represents the relationship between a bond’s term to maturity and its yield at a given point in time.
Yield to maturity: The fully compounded rate of return earned by an investor over the life of a bond, including interest income and price appreciation.
Institutional info: www.HealthcareFinancials.com
More terms: www.HealthDictionarySeries.com
Note: Feel free to send in your own related terms and definitions so that this section may be updated continually in modern Wiki-like fashion.
Filed under: Portfolio Management | Tagged: Investing Basics | Leave a comment »
Understanding Company Specific Risk
By Julia O’Neal; MA, CPA
There are several kinds of investing risk, for example:
Business Risk Example
An example of high business risk would be a computer component manufacturer whose product demand is highly sensitive to macroeconomic activity and who has small profit margins.
Assessment
A company’s unique business risk would be increased by adding debt to an already unpredictable business.
Conclusion
Can you appreciate that credit risk is associated with a firm’s ability to meet financial obligations on the securities [bonds, notes and obligations, etc.] it issues?
More importantly, do you invest with this risk in mind?
More info: http://www.springerpub.com/prod.aspx?prod_id=23759
Individual: http://www.jbpub.com/catalog/0763745790/
Institutional: www.HealthcareFinancials.com
Terms: www.HealthDictionarySeries.com
Filed under: Risk Management | Tagged: Investing Basics | Leave a comment »
New CMS Healthcare Finance Rules for Fiscal 2008
By Dr. David Edward Marcinko; MBA, CMP™
The Centers for Medicare & Medicaid Services (CMS) just released the final Inpatient Prospective Payment System [IPPS] rules for fiscal year 2008. The lengthy official version was published in the Federal Register on August 22, 2007.
The good news is that overall Medicare payments to hospitals should increase by an average of 3.5%. The bad news is a plethora of additional compliance regulations.
A Brief Review
And so, since it has been said that brevity is the surest route to perusal, the most important of these new payment and policy provisions include:
Enter the MS-DRGs
Perhaps the biggest changes relate to the revisions of certain long-term care hospital policies, including the transition to the MS-DRG system over two years, refinements to the relative weights for the DRGs, and application of a budget neutrality factor to the annual rate update (but not the “behavioral- offset” that will apply to acute hospital payments).
Assessment
Therefore, let all related information in our two-volume print subscription publication Healthcare Organizations: [Financial Management Strategies] guide your leadership decisions with alacrity.
Conclusion
How will the above new rules and regulations affect you and/or your healthcare institution? Your cogent thoughts, and informed opinions, are always appreciated.
Speaker: If you need a moderator or a speaker for an upcoming event, Dr. David Edward Marcinko; MBA – Editor and Publisher-in-Chief – is available for speaking engagements.
Contact him at: MarcinkoAdvisors@msn.com
Bio: http://www.stpub.com/pubs/authors/MARCINKO.htm
Order the Premium Print Guide: http://www.stpub.com/pubs/ho.htmThe subscription print guide includes up to four annual quarterly updates. Now, enjoy a 30-day risk-free trial as a two-volume guide in a unique loose-leaf binder format. Special introductory price: $525/yr. Call 1-800-251-0381. More information: www.stpub.com/pubs/ho.htmTo email purchase: email: orders@stpub.com
Filed under: Healthcare Finance | Tagged: Health Care Finance | 1 Comment »
Medical Accounting News for 2008
Staff Writers
By now, most physician business-owners understand the general rules regarding the filing requirements for Form 1099-MISC.
IRS Form 1099-MISC in Review
Nevertheless, in review, Forms 1099-MISC should be issued to independent entities performing services for your medical practice or business entity. 1099s should be sent to individuals with annual earnings exceeding $600. There is no requirement to file Forms 1099-MISC to corporations.
The Forms should be mailed to the recipients no later than January 31st, and no later than February 28th 2008, to the IRS.
Your Vendors
The starting point in this process is your attempt to learn more about a vendor, subcontractor, janitor, accountant, attorney, software and medical practice management consultants, etc.
This is accomplished by requesting the entity to complete a Form W-9, which will reveal the legal status of the vendor, i.e. LLC taxed as a sole proprietor, an LLC taxed as a partnership, a corporation, a sole proprietor, etc.
Assessment
Always request and maintain a Form W-9. Why? Protection from the IRS! Failure to obtain and maintain Form W-9 can lead to the Federal backup withholding tax of 25% to 28%.
Forms W-9 are available from the IRS Website.
Conclusion:
And so, are you familiar with these medical accounting risk management principles for Form 1099-MISC?
Related info: http://www.jbpub.com/catalog/0763745790/
Terms: www.HealthDictionarySeries.com
Institutional: www.HealthcareFinancials.com
Filed under: Accounting | Tagged: Accounting in Medicine | 1 Comment »
Why Medical Providers are Dis-enfranchised
Dr. David Edward Marcinko; MBA CMP™
[Publisher-in-Chief]
Despite the purported benefits of managed care, anecdotal evidence suggests that MD’s are less happy about managed care, compensation and their profession than ever before. Some might say they are even “desperate.”
There are other reasons for despair, as well:
Furthermore, such cuts also stand to hurt physicians with private payers since commercial insurers often tie their reimbursement schedules to Medicare’s resources.
Of course, many doctors feel that the profession of medicine is no longer satisfying or ego enhancing since almost 40% are now merely corporate employees.
And in the past few years, the following has occurred:
Assessment: And so, do you believe the above is more true than not; and are doctors really getting desperate?
Conclusion: Your thoughts are appreciated.
Speaker: If you need a moderator or a speaker for an upcoming event, Dr. David Edward Marcinko; MBA – Editor and Publisher-in-Chief – is available for speaking engagements. Contact him at: MarcinkoAdvisors@msn.com
***
***
Filed under: Career Development, Touring with Marcinko | Tagged: Career Development | Leave a comment »
The US Supreme Court Rules
[By Staff Reporters]
Did you know that the US Supreme Court just ruled that makers of medical devices – like implantable defibrillators or breast implants – are immune from liability for personal injuries as long as the Food and Drug Administration [FDA] approved the device before it was marketed and it meets the agency’s specifications?
Background
In 2004, the administration reversed longstanding federal policy and began arguing that “premarket approval” of a new medical device by the FDA overrides most claims for damages under state law, but because federal law makes no provision for damage suits against device makers, injured patients have turned to state law and have won substantial awards, according to the New York Times.
The Ruling
The decision does not foreclose lawsuits claiming that a device was made improperly, in violation of Food and Drug Administration [FDA] specifications, while cases may also be brought under state laws that mirror federal rules, as opposed to supplementing them.
Devices subject to the premarket approval process, and thus affected by the court’s opinion, tend to be more technologically advanced and expensive, while examples of devices that have been the subjects of recent lawsuits include an implantable defibrillator, a heart pump, a spinal cord stimulator, a drug-coated stent, an artificial heart valve, and prosthetic hips and knees.
***
***
Assessment
The Bush administration plans to continue its push for pre-emption from personal injury suits in another FDA case that the court has accepted for its next term, on whether the agency’s approval of a drug, as opposed to a device, pre-empts personal injury suits.
And so, is this ruling a boon for trial lawyers or patients; both or neither?
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
Filed under: Drugs and Pharma | Tagged: Drugs, FDA, Health Law & Policy | 2 Comments »
Understanding Qui Tam
[By Dr. Charles F. Fenton III; Esq
]
A civil war era law, titled the False Claims Act (qui tam [in the name of the king]), is increasingly popular with prosecutors who pursue inappropriate billing mishaps by physicians.
Why the False Claims Act?
The FCA rose to prominence because in 1990, the healthcare industry accounted for about 10% of all false claims penalties recovered the federal government. By 1998, the healthcare share was almost 40%. Today, it may be even more.
The “Act”
The False Claims Act allows a private citizen such as your patient, your employee, or a competing doctor to bring a health care fraud claim against you, on behalf of and in the name of the United States of America. The “relator” who initiates the claim is rewarded by sharing in a percentage of the recovery from the health care provider.
Essentially, the “Act” allows an informant to receive up to 30% of any judgment recovered against government contractors (Medicare, Medicaid, CHAMPUS, prison systems, American Indian reservations or the VA systems, etc).
With a low burden of proof, triple damages, and penalties up to $10,000 for each wrongful claims submission, these suits are the enforcement tools of choice for zealous prosecutors pursuing health fraud.
Assessment
All that must be proven is that improper claims were submitted with a reckless disregard of the truth. Intentional fraud is irrelevant to these cases, even if submitted by a third party, such as a billing company.
It is imperative that the attending physicians review all bills before they are submitted to any state of federal agency. The Federal False Claims Act is a federal law that has been on the books since the days of the civil war and which recently has become a tool to battle health care fraud.
So, what do you think about the Federal FCA?
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
Filed under: Glossary Terms, Health Law & Policy | Tagged: Charles Fenton, false claims act | 6 Comments »
It’s Insurance Carriers versus Medical Providers
Dr. David Edward Marcinko; MBA CMP™
[Publisher-in-Chief]
Some of the benefits for corporate America (payers), who supply the majority of health insurance to employees (insureds) through managed care organizations [MCOs] are listed below.
MCO Carrier Benefits
Medical Provider Benefits
The following is a brief list of the benefits physicians supposedly may derive by participating in managed care plans:
Assessment
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
Filed under: Managed Care | Tagged: Managed Care | 2 Comments »
Dear Medical Executive-Post
This is an excellent communications forum and blog; I tell all my friends about it. So, here is my dilemma.
The Problem?
My financial planner charges me a percentage of assets-under-management. He explained that in this way we are both on the “same side of the economic table”, with aligned interests. It all sounded good at first; but now I am wondering after doing some research and readings?
For example:
Assessment
Is it time for me to “do-it-myself”; and go to a passive investment management style, use index funds or ETFs, and be done with it all? This strategy sure seems a lot cheaper. Of course, I fear my “doubts” will affect our relationship.
Conclusion
Am I wrong, or right? The more I investigate and learn about all these industry practices, the more concerned I have become. Any thoughts are appreciated? Yet, maybe I don’t really have a problem at all!
Nevertheless, where does a doctor (or anyone else for that matter) go for “honest advice”?
PS: Your books are excellent sources, but I still need some help with execution.
Thank you.
Dr. Mark-Me Anonymous
[Washington, DC]
***
***
Filed under: "Ask-an-Advisor" | Tagged: Ask a Consultant | 6 Comments »
Clinical Laboratory Improvement Amendments
By Patricia A. Trites; PhD, MPA, CHBC, CMP™ (Hon)
The Clinical Laboratory Improvement Amendment (CLIA) was passed in 1988 and pertains to any healthcare provider or entity that performs any laboratory test.
A Series of Acts
This legislation is actually a series of acts that established quality standards for laboratory testing in order to ensure the accuracy, reliability and timeliness of patient test results regardless of where the test was performed.
Certification Types
Providers must register with the Centers for Medicare and Medicaid Services (CMS) by filling out an application and paying the required fees. These fees vary upon the type or complexity of certificate requested. After completing all of the requirements, the provider will receive a CLIA Certificate.
The four types of CLIA certificates are:
Revised Regulations
In 1997 CMS enacted a new regulation that requires providers to include their CLIA number on all claim forms (ex: HCFA/CMS 1500) that contain requests for payment for clinical laboratory services.
This is to insure that: (1) the provider has a current CLIA certificate and, (2) that the provider is performing only the laboratory tests that are allowed for the particular level of certificate. There are specific regulations and documentation requirements for the different levels of service.
Compliance Issues
A recent study in 2001 found that a large percentage of clinical laboratories were not in compliance. It has been recommended that increased inspection, both announced and unannounced, be instituted to better insure the quality of laboratory services.
The CLIA requirements can be found at: http://www.cms.gov/clia.
Assessment
What has been your experience with CLIA?
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
DICTIONARIES: http://www.springerpub.com/Search/marcinko
PHYSICIANS: www.MedicalBusinessAdvisors.com
PRACTICES: www.BusinessofMedicalPractice.com
HOSPITALS: http://www.crcpress.com/product/isbn/9781466558731
CLINICS: http://www.crcpress.com/product/isbn/9781439879900
BLOG: www.MedicalExecutivePost.com
FINANCE: Financial Planning for Physicians and Advisors
INSURANCE: Risk Management and Insurance Strategies for Physicians and Advisors
Filed under: Health Law & Policy | Tagged: Health Law & Policy | 5 Comments »
Corporate Health Group Seeks Best Practice Trends in Physician Relations
Staff Writers
Participate in the 2008 Physician Relations Sales and Service Survey, by Corporate Health Group [CHG], and receive a complimentary executive summary of the national practices and models to help benefit your program for future success!
Physicians still direct the vast majority of healthcare in the marketplace – as many as 80% of patients enter the doors of hospitals and facilities at the direction of physicians.
And, regardless of the movement toward a consumer-driven market, many hospitals, health systems and large specialty practices have turned to physician sales or referral development programs to grow their business. Unfortunately, motivating physicians to change referral patterns is a daunting task under the best of circumstances and the lack of industry “best practices” complicates the situation even further.
In October 2005, Strategic Health Care Marketing [SHCM] teamed with Corporate Health Group [CHG] to conduct a National Survey with the desire to gain insight into healthcare provider’s physician sales efforts. There was an overwhelming response to the online survey and requests for the white paper with data summary results.
Now, Corporate Health Group is once again conducting a survey to capture the best practices for 2008. The 2008 Physician Sales and Service Survey has been expanded to be even more comprehensive.
From the completed survey responses a white paper will be created with detailed management and benchmarking data for physician sales managers and healthcare executives.
A complimentary copy will be given to those that complete the survey and request to receive the results. The survery is now CLOSED.
Additional info: www.HealthCareGroup.com
Corporate Health Group
7 Brayton Meadow, East
Greenwich, Rhode Island 02818 USA
Thank you.
Executive-Post
Filed under: Surveys and Voting | Leave a comment »
Understanding the Waiver of Co-pays and Deductibles
By Patricia A. Trites; PhD, MPA, CHBC, CMP™ (Hon)
Professional medical courtesy and the waiver of co-pays and deductibles is a very controversial subject to healthcare practitioners.
It appears to most people that it should be up to each physician to decide if he/she wants to waive payment for their services or to discount the service. Unfortunately, this practice may be illegal in most instances.
And, there are only a few instances when this “tradition” is legally allowable, such as in the case of indigence of the patient or when the practitioner provides services to an immediate relative or household member.
DHHS Definition
According to the Department of Health and Human Services [DHHS], the “routine waiver of deductibles and co-payments by charge-based providers, practitioners or suppliers is unlawful because it results in:
When the patient has insurance other than Medicare, waiving the co-payment, deductible or the entire charge is violating both the insured’s contract with their insurance company and the physician’s or other provider’s contract or participation agreement.
Exceptions
Financial or medical indigence is an exception. The provider may reduce or waive his/her fee, if the rules are followed. But, a simple statement by the patient that they are unable to pay their share of the service is not enough.
Medicare requires that the provider ask and document the answers to these specific questions.
Does the patient have any other source that may be legally responsible for his/her medical bills?
Examples: Medicaid or Legal Guardian
Can the patient provide information for the practice to perform an analysis of total resources?
Examples:
Assets (only those convertible to cash and unnecessary for the patient’s daily living), Liabilities, and Income and Expenses.
Assessment
Such patient information should be reviewed annually and documented in the financial file.
Conclusion
And so, have you ever run afoul of the law by granting a patient professional courtesy? Do you still grant PC at all?
More info: http://www.springerpub.com/prod.aspx?prod_id=23759
Institutional: www.HealthcareFinancials.com
Filed under: Managed Care | Tagged: Health Care Finance | Leave a comment »
Understanding Changes in Medical Payment Delivery Models
Dr. David Edward Marcinko; MBA CMP™
As healthcare insurance payments have shifted from the older fee for service model, to the newer managed care capitation models, the following characteristics may be observed
Shifting from Retail to Wholesale Medical Models
Contemporary (Managed Care-Capitation) Methodology
A Per Member/Per Month medical capitation model requires the payment of a fixed sum of money to a medical provider to cover a defined set of health care services for an individual enrollee, over a defined period of time.
Under PM/PM capitation, the doctor assumes the risk for the incidence (utilization rate) of medical conditions requiring procedures specified in the MCO contract.
PM/PM Characteristics:
Assessment
Under PM/PM capitation, the MD is at risk for: (a) utilization and acuity (b) actuarial accuracy (c) cost of delivering medical care, and (d) adverse patient selection.
Conclusion
Do you participate in any capitated health insurance plans which have been making a comeback, of late? What has been your experience with them?
More info: http://www.springerpub.com/prod.aspx?prod_id=23759
Terms: www.HealthDictionarySeries.com
Speaker: If you need a moderator or a speaker for an upcoming event, Dr. David Edward Marcinko; MBA – Editor and Publisher-in-Chief – is available for speaking engagements. Contact him at: MarcinkoAdvisors@msn.com
Filed under: Managed Care | Tagged: Health Care Finance | 3 Comments »
A Brief Historical Review of Delivery
Dr. David Edward Marcinko; MBA CMP™
[Publisher-in-Chief]
Prior to 1970s, the healthcare reimbursement system was not a monolithic complex and most Americans received their healthcare through one of five third-party organizations: (1) Blue Cross/Blue Shield (pre-paids), (2) Commercial insurance (private) companies, (3) Medicare (federal-elderly), (4) Medicaid (state-poor) and (5) CHAMPUS (military).
Four Fragmented Participants
The four participants in this fragmented system were; the patient (consumer), the physician (provider), the employer (buyer or payer) and one of these third-party intermediaries (TPIs).
Moreover, the doctor-patient relationship was often muddled by the third parties who became brokers between MD and patient; both who merely sought to understand: (a) who was responsible for payment; (b) how the MD would assist the patient obtain reimbursement, and, (c) how to establish the ultimately responsible party?
Commercial Insurance and the CPI
In the meantime, commercial insurance medical costs were accelerating at a rate greater than three times the Consumer Price Index [CPI], a measure of goods and services in a market basket intended to be representative of a typical patient’s purchases.
There was no single reason for medical cost escalation, but many economists believed the following circumstances conjoined at one point in time to increase health care costs dramatically. Important factors include the following:
1. Law of Supply and Demand (increasingly too many doctors chasing too few patients).
For example, Milliman & Robertson, the actuarial firm, estimated that only about 70% of physicians actively practicing medicine in the United States are necessary; a decade ago. The same situation is true for other healthcare employees. Mergers, acquisitions, outsourcing, closings and consolidations have only exacerbated the situation.
2. The US Federal Budget Deficit is about 3.5 trillion dollars, since income is 1.5 Trillion Dollars and outflow is 5 Trillion Dollars.
On the other hand, the budget surplus that existed several years ago was dissipated by 2005, thanks to the flagging economy and War with Iraq.
Additionally, the federal budget further demonstrates the severity of the healthcare cost problem as a percentage of the national budget:
Increased administrative costs and advancements in health information technology. The primary use of new technology has been in the areas of diagnosis and treatment.
However, HMOs also use technology to increase operational efficiency and reduce costs. The price paid is in the loss of jobs or reduction in the skill level needed to perform certain tasks, formerly done by trained technicians, nurses or physicians.
4. Malpractice phobia, misinformed patients, hungry trial lawyers and class action lawsuits.
The median malpractice award for all medical negligence claims increased by 14% since 2000, and in childbirth cases was $1.3 million, more than double the median for any other type of medical malpractice verdict.
Assessment
According to some industry pundits, even seemingly small healthcare premium amounts matter.
For example, the difference between a high and lost cost health care plan is about $20-25 per member/per month. Nevertheless, low cost provider groups gained enrollment, as high cost providers lost enrollment at this level; in one study.
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact:
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
DICTIONARIES: http://www.springerpub.com/Search/marcinko
PHYSICIANS: www.MedicalBusinessAdvisors.com
PRACTICES: www.BusinessofMedicalPractice.com
HOSPITALS: http://www.crcpress.com/product/isbn/9781466558731
CLINICS: http://www.crcpress.com/product/isbn/9781439879900
BLOG: www.MedicalExecutivePost.com
FINANCE: Financial Planning for Physicians and Advisors
INSURANCE: Risk Management and Insurance Strategies for Physicians and Advisors
Filed under: Healthcare Finance | Tagged: Health Care Finance | 1 Comment »
Moving Toward a More Perfectly Competitive Marketplace
Dr. David Edward Marcinko; MBA, CMP™
Publisher-in-Chief
Some believe it is now time to consider how medical marketplace externalities can be applied to achieve a profit maximizing medical practice. Realize that the imperfect fee-for-service marketplace is moving to become more perfectly competitive in the managed care environment.
Medical Economic Scenarios
For example, consider the following health economic scenarios.
1. A glut of good physicians causes them to become “price takers”, selling a homogenous(commoditized) service. An appendectomy is an appendectomy; or is it?
Financially, many doctors are “taking what they’re given (by MCOs), because they’re working for a living”. Younger doctors under 40 are especially inclined to work for less since they have had little exposure to fee-for-service compensation. Perhaps providers need to “differentiate” themselves from the competition? Ponder the MD vs. DO controversy, since one of the fastest growing areas of specialization is osteopathic family medicine.
Or, consider the potential economic impact of any willing provider laws?
2. Physicians have an increasing smaller share of the medical marketplace because of extended care providers. Does this help or hinder them?
Price information is freely available to all MCO’s because of computerization; and increasingly to consumers and HD-HCPs.
3. Doctors have been defeated in their ability to influence the marketplace by selling a quality, but nevertheless standardized, service. Consider the economic effects of practice guidelines in this light?
4. As medical care becomes efficient, each doctor becomes a perfect substitute for the other. This may either be an accolade, or a curse since patient demand becomes perfectly elastic at the HMO’s capitated set price.
This being the case, there is no incentive to lower fees in an attempt to attract more patients, since doctors would not be able treat any more patients than they would otherwise. The price decrease just lowers income, but has no effect number of patients treated. It simply decreases profits.
5. Since marginal revenue is the fee obtained from seeing one extra patient, marginal revenue becomes equal to HMO price, and marginal profit is zero when marginal revenue just equals marginal cost.
Will the MD still want to wait another hour just to see that last late HMO or Medicaid patient?
6. A profit maximizing office will operate at a short-term loss as long as its minimum average cost is less than its minimum possible average variable cost. But, just how long is “short term”, anyway?
7. Efficiency prevails when medical services are made available just up to the point that marginal benefits equal marginal costs. When efficiency is achieved, it is not possible to make more money without decreasing another doctor’s income in a risk pool situation. Voila – managed competition, anyone?
It is estimated that more than a quarter of all physicians may leave practice by the year 2015.
Assessment
Regardless of the technical nature of the above health economic arguments, practical attention must be directed toward the possibility of governmental (national healthcare) intervention or marketplace (HMO) intercession, relative to two other concepts – not discussed here – that directly affect medical practices; price ceilings and price floors.
Conclusion
Recall all the fee schedule surveys popular several years ago? How does this knowledge impact medical care today?
Can you comment on any other economic scenarios that might encourage medical practice profit maximization?
More info: http://www.springerpub.com/prod.aspx?prod_id=23759
Institutional: www.HealthcareFinancials.com
Terms: www.HealthDictionarySeries.com
Speaker: If you need a moderator or a speaker for an upcoming event, Dr. David Edward Marcinko; MBA – Editor and Publisher-in-Chief – is available for speaking engagements. Contact him at: MarcinkoAdvisors@msn.com
Filed under: Health Economics | Tagged: Health Economics | 1 Comment »
Understanding PPO’s
Dr. David Edward Marcinko; MBA CMP™
Publisher-in-Chief
A preferred Provider Organization (PPO) is a bridge between traditional indemnity insurance and an HMO, and consists of several different types. It attempts to feature the provider choices seen in indemnity insurance, with the non-risk cost reductions seen in HMOs.
PPO Variations
Two similar entities, known as the Exclusive Provider Organization (EPO), and the Point of Service or Swing Out Plan (POS or SOP), consists of an exclusive provider panel who have agreed to accept a deep discount in their medical fees in return for the volume of patients the plans can provide to them.
Assessment
A combination of the above type models has been very successful for many employers, and this model is not as restricted by the HMO Act.
A payment time-line for a typical PPO may look something like the following:
Healthcare Provider bills PPO —> PPO bills company –> Company pays PPO —> PPO pays Provider
Conclusion
Which plan type above do you favor?
More info: http://www.springerpub.com/prod.aspx?prod_id=23759
Terms: www.HealthDictionarySeries.com
Speaker: If you need a moderator or a speaker for an upcoming event, Dr. David Edward Marcinko; MBA – Editor and Publisher-in-Chief – is available for speaking engagements. Contact him at: MarcinkoAdvisors@msn.com
Filed under: Managed Care | Tagged: Health Care Finance | Leave a comment »
Physician Investing Basics
[By Julia O’Neal; MA, CPA]
American Depository Receipts [ADRs] are shares of foreign stocks held by U.S. banks abroad that are sold on exchanges in the United States.
Often, foreign governments do not allow stocks to be sold to non-citizens, and ADRs allow U.S. investors to purchase foreign securities.
ADRs usually exist on only the largest foreign publicly held companies, but their numbers are rapidly growing. They are traded in dollars, and dividends are paid in dollars. (Morningstar, Inc., in Chicago, publishes regular research reports on ADRs.)
Assessment
Do you own ADRs, and why or why not?
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
Filed under: Investing | Tagged: Investing Basics | 2 Comments »
Medical Talent, Supply-Demand and Global Economics
A new study from the General Accountability Office [GAO] indicates that the number of US doctors specializing in primary care is falling.
Now, that’s the bad news, and one wonders if this is a result of the income-gap disparity between generalists and specialists?
Statistics
The good news is that the numerical gap is being covered by doctors who move here from other countries.
The report states that there were 22,146 American doctors in residency programs for primary care practice, down from 23,801 in 1995. Meanwhile, the number of international medical graduates training in primary care climbed from 13,025 in 1995 to 15,565 in 2006.
Ugh! Did we say “good news?”
Assessment
The presence of foreign-born physicians goes well beyond primary care.
For example, one in four new physicians is currently an international medical graduate, according to Sen. Bernie Sanders (I-VT), who spoke at a Senate Health, Education, Labor and Pensions Committee meeting where the report was presented.
Conclusion
And so, is this an example of basic economics 101 in-play, and a modern type of reverse in-sourcing of medical talent? Worker unions, take note.
Institutional info: www.HealthcareFinancials.com
Filed under: Career Development | Tagged: Health Economics | 1 Comment »
“What’s up with That?”
By Patrick C. Cox, Jr
How many times have you viewed the Lipitor® “educational” commercial featuring Dr. Robert Jarvik?
If you are like me, probably often since Pfizer appears set on getting their money’s worth from the production. The spot pops up everywhere it seems. Pretty impressive with the rowing, the lake, and natural beauty along with a heartfelt pitch from Jarvik on what a difference Lipitor® has made in his life.
He shares his thoughts that Lipitor® is one of the most researched drugs and he’s glad that he takes it as a doctor, and a dad.
Well, the commercial may have run one time too many. Questions have been raised by consumers and now congressional figures as to Jarvik’s credibility and his Lipitor® endorsement.
For example, he never pursued a medical internship, is not licensed to practice and can’t legally prescribe.
Of course, Jarvik has been recently defending his status as a scientist and his role in simply educating the public in the ad. But, his revelation as a past Lipitor® patient, with implied personal endorsement, could certainly make patients feel they’re missing something if they too aren’t taking the compound.
Assessment
Of course, we all know the real reason behind the ad. Pfizer has invested millions hoping Jarvis’s personal endorsement will get patients saying to themselves, “Hey, Dr. Jarvik prescribes it for his patients and takes it himself, how come I’m not on it?”
The next step they’re hoping for is for them to ask their “prescribing” physician the same thing.
Assessment
Well that’s the problem, isn’t it? Lipitor® is a good drug, but it’s not for everyone. And, only doctors should know what’s best for their own patient’s; right?
So, should drug companies be held accountable for these ads and/or provide more disclosure to the public?
In other word’s, should Pfizer have told us that Jarvik isn’t really a doctor, can’t and isn’t prescribing anything to anyone – and wait a second – did he really even take Lipitor® at all?
Guess only his “prescribing” physician would know, for sure!
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
Filed under: Drugs and Pharma | Tagged: Big Pharma and Drugs | 5 Comments »
Army Bronze Star Medal Interview
Recently, Medical Executive-Post writers caught up with Captain Cecelia T. Perez for more information on the exact circumstances surrounding her Bronze Star Medal Award.
Interview Synopsis
Self-effacing and humble, Cecelia simply stated in her email interview that the medal was “basically for saving lives” while in Iraq.
Only when pressed for more details, did Cecelia explain – “My friend Bill and I set up trauma sites separate from the rest of our company. First, in Talafar, Iraq for five months and then at COP Gabe in Baquoba, Iraq during our brigade’s retaking of that city.”
She noted that “we had some serious trauma to deal with as we responded to Iraqi Army mass casualty events at their aide station which was also located near us.”
Unfortunately, “they did not have a PA or doctor like we did, so Bill and I, along with our medics, responded to their requests for help.”
Of course, Cecelia mentioned several times that it was a medical team group effort.
But, “they obviously appreciated our efforts as gender, racial, and cultural barriers disappear in the midst of the bleeding and the wounded.”
Assessment
We say: A real American Army Hero would have it no other way!
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
Filed under: Military Medicine | Tagged: Bronze Star Medal, cecelia perez, Military Medicine | 4 Comments »
Defying Traditional Economic Principles
By Dr. David Edward Marcinko; MBA CMP™
It is well known that traditional medical marketplace supply and demand structures are not necessarily efficient or timely. This is particularly true in healthcare delivery and is attributed to various “externalities” that seemingly deter competition.
Defining Economic Externalities
Formally, externalities are defined as the cost or benefits of market transactions that are not directly reflected in the price buyers (patients) or sellers (doctors) use to make their decisions. They represent defects or inefficiencies in the pricing system and can be either positive or negative.
Medical Externalities
Pertinent externalities for the physician, and healthcare practitioner, include but are not limited, to the following:
1. Barriers to Entry: Physicians and other “learned healthcare professionals”, receive an extended formal education. This not only ensures competence and protects the public, but it also reduces competition.
2. Competitive Advantage: Once school is over, a medical degree is an effective strategic advantage over a non-degreed practitioner.
3. Monopsony and Oligopsony: Occur when discounts are extracted from healthcare providers because of supply and demand size inequalities, and may run afoul of anti-trust laws.
4. Barriers to Exit: The increased cost of “doing business”, effectively precludes many physicians from terminating practice unit all fiscal investments are recouped. Observe that few doctors can practice “part time” and still afford their overhead.
5. Mortal turpitude: Since physicians take the “Hippocratic Oath”, they are expected to place patient welfare above their own. This is not necessarily true with business entities that must adhere to legalities only.
6. Moral Hazards: All know that cigarettes, dietary indiscretions, drinking, drug use and promiscuous behavior are unhealthy. Yet, many pursue this life‑style that drive up healthcare costs for society as a whole.
Other Externalities Exist
Other externalities that drive up the cost of healthcare are well known but not easily changed.
First, most Americans have group insurance through their employment. They do not “purchase” it on the open market, making them fairly indifferent to the costs or needs of individual health care purchases.
Second, acquiring health insurance is not like buying a commodity, and it is difficult for a layman to know what purchases make sense and at what price?
Third, most health insurance purchasing decisions are made by the doctor (i.e., refer to a specialist or have surgery), not the patient consumer, and hence has a vested interest in increasing service demand. This is changing with the consumer directed healthcare plan movement.
Lastly, what well informed person would be a tough bargainer when their health is at stake? Who is going to negotiate with a neuro-surgeon? Nevertheless, some patients are doing just that with HD-HCPs!
The Golden Age of Medical Reimbursement
During the so called “Golden Age of Medicine“, 1965-1990, Medicare, Medicaid and all these factors worked to isolate American medicine from financial reality.
In the last decade, however, the private sector has demanded cost containment by negotiate prices for medical services.
Conclusion
Can you comment on other externalities that seem to defy traditional healthcare supply and demand economics?
More info: http://www.springerpub.com/prod.aspx?prod_id=23759
Terms: www.HealthDictionarySeries.com
Institutional: www.HealthCareFinancials.com
Speaker: If you need a moderator or a speaker for an upcoming event, Dr. David Edward Marcinko; MBA – Editor and Publisher-in-Chief – is available for speaking engagements. Contact him at: MarcinkoAdvisors@msn.com
Filed under: Health Economics | Tagged: Health Economics | 5 Comments »
Physician Investing Basics
[By Julia O’Neal; MA, CPA]
There are several different types of common stock listed below, and more.
Utilities: Utilities are companies in public-service businesses, such as electric utilities, natural gas delivery, or telephones, which pay high dividends and are often used by investors for income.
Blue chips: These are high-quality, well-known, large-capitalization, dividend-paying companies with long track records of steady, secure earnings.
Capitalization: Market price × Number of shares outstanding. Usually market cap of less than $500 million is considered “small capitalization,” but in recent years, companies between $500 million and $1 billion are also being considered “small caps.”
Growth: Companies with earnings growth in excess of industry or market averages. Although these companies have strong earnings, they usually reinvest them into research or expansion rather than pay them out as dividends.
Emerging growth: Smaller capitalization companies with even stronger earnings potential. Smaller companies are on the early part of the growth curve. While the start-up phase is the riskiest, the expansion phase follows, where growth is the fastest. Small companies may be in new businesses or new markets, and they often have the advantage of being able to react quickly to change. Some investors look especially for smaller companies that are “under-owned by institutions”—that have not been discovered by the big professional investors.
Cyclical: Companies in businesses providing basic materials or products that are subject to the economic cycle; profits are based on increased consumer demand for high-cost items that can be deferred in tough economic times. Some examples are steel, autos, and building materials. These may be big, strong, mature companies that pay dividends, but they are not blue chips because the possibility exists that earnings may slump drastically and dividends may disappear during economic downturns.
Defensive: Companies that continue to produce earnings in all economic cycles because they provide a necessary product or service (for example utilities, healthcare and food companies).
Assessment
Of course, stocks are further subdivided by industry type, from retailing (department stores and other direct sellers to consumers) to restaurants to technology to steel. The list is long, and sectors are often classified differently.
New areas, such as bio and nano-technology and networking software, are constantly being added.
Conclusion
And so, do you prefer common stocks, mutual funds, index funds or ETFs, and why?
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
DICTIONARIES: http://www.springerpub.com/Search/marcinko
PHYSICIANS: www.MedicalBusinessAdvisors.com
PRACTICES: www.BusinessofMedicalPractice.com
HOSPITALS: http://www.crcpress.com/product/isbn/9781466558731
CLINICS: http://www.crcpress.com/product/isbn/9781439879900
BLOG: www.MedicalExecutivePost.com
FINANCE: Financial Planning for Physicians and Advisors
INSURANCE: Risk Management and Insurance Strategies for Physicians and Advisors
Filed under: Investing | Tagged: blue chip, capitalization, common stock, cyclical, defensive, equities, Investing Basics, utilities | Leave a comment »
Physician Investing Basics
Common stock is fractional company ownership and does not have to pay a specified dividend. It is assigned a par value only for bookkeeping purposes on the balance sheet. (Additional value of book equity is called paid-in capital or capital surplus.)
Par Value not Market Value
Par value has no relation to market value. Some types of preferred stock do not carry voting privileges, but common stockholders must vote on certain corporate matters, such as the election of the board of directors.
Classes
Moreover, there are some companies that offer two, three or more different classes of stocks under Common Stocks. They often call these as Class A, Class B and Class C, etc. Class A stock holders have literally more voting rights than Class B stock holders, and so forth.
Company stocks that have more than one class is not a common stock and most physicians and investors refrain from buying company stocks with more than one class; unless carefully evaluated.
Stockholders are invited to attend the annual meeting to vote, but may also vote by mail, in a proxy vote.
Conclusion
And so, how much common stock do you own?
Filed under: Investing | Tagged: Investing Basics | 1 Comment »
Healthcare price ceilings and floors benefit certain groups but impair the distribution of medical goods and services by the price system in free competitive markets.
And, government intervention interferes in the functioning of competitive markets and is likely to result in “resource allocation” problems.
Health Economics Definitions
“Price ceilings” are maximum legally charges and always result in shortages when set below market equilibrium prices. How long is the wait at a local charitable hospital vs. a local for-profit medical center? Price ceilings often result in an underground black market economy that exceeds legal limits.
Non-price rationing (i.e., free medical care) on the other hand, distributes available services to patients on a basis other than ability to pay. The most common non-price rationing device is, “first-come, first-served”.
“Price floors” establish minimum prices, which often result in surpluses when they exceed equilibrium price levels. The minimum wage is a good example of a price floor.
Assessment
Remember, Keynesian macro-economic philosophy. In evaluating managed care price controls, the gains to beneficiaries of price ceilings and floors must be weighed against the resulting allocation problems.
Alternative methods that will make the gainers just as well off without impairing the rationing function of medical prices, can be considered as ways to increase efficiency in the medical economy.
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
DICTIONARIES: http://www.springerpub.com/Search/marcinko
PHYSICIANS: www.MedicalBusinessAdvisors.com
PRACTICES: www.BusinessofMedicalPractice.com
HOSPITALS: http://www.crcpress.com/product/isbn/9781466558731
CLINICS: http://www.crcpress.com/product/isbn/9781439879900
BLOG: www.MedicalExecutivePost.com
FINANCE: Financial Planning for Physicians and Advisors
INSURANCE: Risk Management and Insurance Strategies for Physicians and Advisors
Filed under: Health Economics | Tagged: Health Economics | 4 Comments »
Physician Investing Basics
By Julia O’Neal; MA, CPA
Preferred stock is designed to resemble bonds and usually has a par value of $100. Dividends are stated as a percentage of par—6% preferred would pay $6 annually. The stated dividend is the minimum that the company will pay out. If there are not enough earnings to pay the dividend, the company will pay out whatever is available for dividends.
Preferred Stock Differences
There are different types of preferred stock, which are based on the method of dividend payment.
Cumulative preferred carries a provision that all prior dividends due on preferred stock must be paid before dividends can be paid on common stock.
Participating preferred may earn dividends in excess of the stated percentage if they are available after dividends are paid on common.
Convertible preferred is also issued at $100 par. The stock may be converted into (exchanged for) a designated number of common shares. The conversion ratio and conversion price are determined at the time the stock is issued.
Conversion ratio = Par value / Conversion price
When the stock reaches its conversion price, the cumulative preferred stock is said to be “at parity” with the common stock.
Cumulative preferred stock usually sells “at a premium to” (above) its par value because of the added value attached to the conversion feature. Most of the time, cumulative preferred stock is callable, which means the corporation has the right to “call” or buy back the preferred stock at a specified price, sometimes after a set date.
Cumulative convertible preferred stock is popular. Investors appreciate the ability to combine the attributes of both stock and bond ownership in one vehicle and, because they are so popular, corporations can market these securities easily, often with a lower coupon than a straight bond would require.
MORE: C v P
Assessment: Is preferred stock best for personal or corporate portfolios?
Conclusion: Your thoughts are appreciated.
***
Filed under: Investing | Tagged: Investing Basics | Leave a comment »
Bonze Star Medal for Captain Cecelia T. Perez; RN
Breaking News Washington, DC
***
THE UNITED STATES OF AMERICA
TO ALL WHO SHALL SEE THESE PRESENTS, GREETING: THIS IS TO CERTIFY THAT THE PRESIDENT OF THE UNITED STATES OF AMERICA AUTHORIZED BY EXECUTIVE ORDER, 24 AUGUST 1962 HAS AWARDED
THE BRONZE STAR MEDAL
To: CAPTAIN CECELIA T. PEREZ
CHARLIE COMPANY, 296th BSB, 3rd BRIGADE, 2nd INFANTRY DIVISION
For: Exceptionally meritorious service while assigned as the Brigade nurse during Operation Iraqi Freedom. Captain Perez’ exceptional dedication to mission accomplishment, tactile competence and unparalleled professionalism contributed immeasurably to the Unit’s success during combat operations. Her actions reflected distinct credit on her, the multinational Division-Baghdad, and the United State Army.
– 5 July 2006 to 5 October 2007 –
GIVEN UNDER MY HAND IN THE CITY OF WASHINGTON, DC
Joseph F. File, Jr. Major General, USA
Commanding: PO #259-100
16 September 2007
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
Filed under: Military Medicine | Tagged: Military Medicine | 3 Comments »
Physician Investing Basics
[By Julia O’Neal MA, CPA]
When companies first go public they issue stock in an initial public offering (IPO). Most of the time these stocks are sold in large blocks to institutional investors and it is only after they begin trading on the exchanges that individuals, like physicians, can buy them. Sometimes these issues are very desirable—they may rise significantly even on the day of issuance.
However, over the longer term the excitement tends to dissipate, and it is much easier to evaluate a company once it has settled into a “trading range.”
Outstanding Stock
Once stock is sold to the public it is called outstanding.
Primary Offerings
A company’s corporate charter usually has authorized more stock for future issuance. When this stock is issued it is called a primary offering (as distinguished from the IPO).
Secondary Offerings
A secondary offering is the re-issue to the public of a large block of shares that has been previously held by a large investor. A primary offering is issued by the company itself and a secondary offering is handled for an outside investor by investment bankers.
Rights Offerings
More shares of stock in a company with the same assets dilute the value of the currently outstanding shares. When more stock is offered to the public, existing common shareholders have a right to buy enough shares to maintain their proportionate share in the company—they are offered the opportunity in a “rights offering,” and usually the shares to be purchased with preemptive rights are offered at a subscription price below current market price.
Rights, like warrants, allow an investor to buy a certain number of shares or portions of shares at a certain price and may be traded. Unlike warrants, rights expire after a certain period of time. When offered rights, an investor should examine the offering prospectus to determine what the newly raised capital will be used for.
Stock Buy-Backs and Treasury Stocks
Outstanding shares are attributed their pro rata portion of earnings. When companies buy back their own stock in a “stock buyback,” it is called “treasury stock” and does not participate in earnings or dividends. This action reduces the number of shares and makes existing shares more valuable while allowing them to receive a larger portion of earnings.
It is positive for a company to buy back stock and negative for it to issue more stock—more outstanding stock is dilutive to earnings and to the value of existing stock. It is also positive when management of a company (“insiders”) buys stock—it usually means that those closest to the company believe it is undervalued.
Warrants
Warrants are attached to bonds in order to allow the bond issuer to make the securities attractive with a lower-than-market coupon. Warrants also have a subscription price that is usually lower than the market price of the stock, so once they are separated from the bonds they have an intrinsic value. Warrants may remain effective for several years or in perpetuity. Dividends are not paid on warrants.
Channel Surfing the ME-P
Have you visited our other topic channels? Established to facilitate idea exchange and link our community together, the value of these topics is dependent upon your input. Please take a minute to visit. And, to prevent that annoying spam, we ask that you register. It is fast, free and secure.
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
Filed under: Investing | Tagged: Financial Markets | 1 Comment »
United States Pharmacopeia [USP]
Staff Reporters
After examining records submitted by 870 hospitals to MEDMARX, a database run by the United States Pharmacopeia (USP), a new report finds that 1.4 percent of mistakes resulted in patient harm, including seven errors that may have caused or contributed to death. The study implicated 1,470 different drugs in errors associated with brand or generic names that looked or sounded similar. The USP compiled an even longer list of 3,170 name-pairs that looked or sounded alike.
Assessment
Medication mix-ups doubled since 2004 driven largely by a troubling proliferation of prescription drugs with confusingly similar names. The 2008 total is nearly double the 1,750 pairs that USP identified in the 2004 study.
Conclusion
And so, how is this possible with bar-coding, RFID tags, eMRs, CPOEs and related modern inventory management technologies?
Related info: www.HealthcareFinancials.com
Terms: www.HealthDictionarySeries.com
Filed under: Drugs and Pharma | Tagged: Big Pharma and Drugs | 1 Comment »
Understanding “Medical Necessity” Billing
By Patricia A. Trites; PhD, MPA, CHBC, CMP™ (Hon)
Some doctors, healthcare executives and/or their insurance or billing advisors do not realize that just because an item or service is not “medically necessary” for billing purposes (in other words, a payable diagnosis); that same item or service may be perfectly necessary for the health or welfare of the patient.
This is where Advance Beneficiary Notices (ABNs) can save the medical practice or healthcare organization much time and money in the billing process.
Defining the ABN
Advance Beneficiary Notices [ABNs] are statements that are given to the patient to read and sign whenever a provider believes that the item or service may not be covered (paid) by Medicare.
Reasons for Use
This may occur when there are a limited number of services that can be performed in a specific time frame, such as, mammography, PSA, colonoscopy, etc.
It can also be used when a patient insists on a specific treatment or test, even when the physician believes the service is unwarranted or unnecessary, but understands that failing to provide the service may put him/her at risk under professional liability standards.
Risk Transfer Mechanism
When an Advance Beneficiary Notice has been signed by the patient, it removes the risk of non-payment from the provider.But, Advance Beneficiary Notices cannot be given to every patient or for all procedures or services.
Assessment
There must be a reasonable expectation that payment will be denied because there is a lack of medical necessity (for billing/ payment). To access complete instructions for the use of ABNs and copies of the specific form that must be used for Medicare patients, go to https://www.cms.gov/
Conclusion:
What has been your experience with ABNs, as a medical provider and/or healthcare executive?
***
***
Filed under: Practice Management | 3 Comments »
Understanding the Legal Process
[By Dr. Jay S. Grife JD MA]
[By Dr. David E.Marcinko MBA]
Depositions are a legal discovery method that deserves specific discussion because the deposition, or oral statement under oath, is such a vital piece of the puzzle.
In general, either party may depose any other person but in general, a deponent has some relevance to the case, whether it be as a fact witness, an expert witness, or a before and after witness (a person who can testify as to the state of affairs of a person before and after the incident in question).
Gaining Insight
Depositions are taken to gain an insight into what information will be necessary in order to prosecute or defend a case. Even more important is that the oral deposition provides the respective lawyer with a chance to evaluate that person’s reactions to stress, to personally see for the temperament of the witness, to view the witness’ demeanor, and to analyze how that person responds to spontaneous events.
Deposition Format
The format is typically oral and in person question and answer dialogue although recent technology has permitted depositions via telephone conference, video-conference, and various internet medium exchanges. Depositions can be taken via written question format but often this type has limited value because the deponent will not be asked any follow-up questions and a statement cannot be investigated further.
Do’s and Don’ts for Doctors
There are many lists of do’s and don’ts that lawyers often provide their clients, but the fundamental character of the deposition is for the deponent to tell the truth. While it is rare that a trial sees the Perry Mason moment, these do in fact happen and when it does, the result is often exactly what viewers of that classical television series see.
Skeletons in the Closet
As a rule, in light of the attorney client privilege, I insist upon knowing whatever skeletons are in my client’s closet, past or present. It is of ultimate importance that a client confides the truth to their lawyer so that the any adverse issue can be addressed through cognizant decision, rather than surprise.
In a recent case, my client was being deposed and admitted to me that she was a lesbian. Her sexual preferences did not matter but the fact that she disclosed a misdemeanor arrest for marijuana did. I advised her to tell the truth about both issues and explained why this was important. During her deposition, when the homophobic defense counsel abrasively probed her sexuality, she readily admitted her own sexual preference. That was fine but the defense lawyer continued to “push her buttons’ until she finally screamed at him to “shut the f… up”.
The die was cast because the next line of questioning involved her arrest record as to the marijuana. When my client denied any other arrests but for the drugs, it was simple for the defense counsel to show her documentation of four earlier felony arrests including one for fraud, which ultimately cost her the case.
The important fact to remember is that we all have a past and that being truthful as to its content can often dictate a successful outcome of a case.
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
***
Filed under: Health Law & Policy | Tagged: Malpractice Liability | 2 Comments »
Proper Use / Billing of CPT® and Diagnosis Codes
The health care industry operates in a heavily regulated environment with a variety of identifiable risk areas. An effective compliance program helps mitigate these risks.
-Corporate Responsibility and Corporate Compliance [A Resource for Health Care Boards of Directors]
The Five Cardinal Compliance Rules to Follow
By Patricia A. Trites; PhD, MPA, CBC, CMP™ [Hon]
After completing and documenting a medical service, the next step is to “code” the procedure and the diagnosis for payment.
The Rationale
CPT® codes are updated annually and each healthcare organization should be sure to use current codes.
And, it is also important to make sure that these codes are not contingent upon whether payment will be made for the service, but should reflect the service(s) and the reason for the service(s) provided.
Much has been written on selecting the correct procedure codes and the associated documentation that is required for each level of service. There are also rules associated with selecting the correct diagnosis code. The key issue in determining if a provider can be paid for their services is to show that there was a medically justifiable reason for performing the procedure or service.
Justifiability Requirements
Justifiability is established primarily by looking at the CPT® or procedure code that was billed in relation to the ICD-9 or diagnosis code that was given as the reason for the encounter or procedure. If medical necessity can be shown, the likelihood is that the bill will be paid.
The Cardinal Rules
The basic requirement is that the diagnosis must justify the procedure. If the following five rules are followed, there is a much better chance that the claim(s) will be paid.
Conclusion
As a provider or medical executive – do you code yourself or use an ancillary coder; in-house or out-sourced and why? Please opine and comment.
More info: http://www.springerpub.com/prod.aspx?prod_id=23759
Institutional: www.HealthCareFinancials.com
Terms: www.HealthDictionarySeries.com
Filed under: Practice Management | Tagged: Coding and Compliance | Leave a comment »
Understanding the Legal System
By Dr. Jay S. Grife; JD, MA
Since most medical negligence cases are fact driven, the topic of discovery demands a specific and integral role in the trial process. Discovery simply is the methodology used in American jurisprudence for each side to discover all of the evidence that is available in the case and to have that documentation analyzed. While specific states have rules that may limit discovery, the purpose is to prevent trial by ambush.
Federal Rules of Civil Procedure
According to the Federal Rules of Civil Procedure [FRCP], discovery can include written interrogatories or questions, requests for production, deposition, either oral or through written statements, request for examination, request for inspection of evidence, requests for admission, and finally independent, or as Plaintiffs’ lawyers commonly label them, compulsory medical examinations.
Definition and Scope
The scope discovery methods are generally a book onto itself. So, suffice it to say, discovery is the process where each party exchanges information so the merit of their respective cases can be evaluated. Lawyers will use this evidence in developing the theory of their case and the order in which that evidence will be presented to the trier of fact.
Conclusion
While discovery is often viewed as a mundane part of the litigation process, in reality it is the very topic that often proves dispositive in the ultimate outcome of a medical malpractice case; whether it is tried, settled, or rejected.
And so, your comments are appreciated?
More info: http://www.jbpub.com/catalog/9780763733421/
Terms: www.HealthDictionarySeries.com
Filed under: Health Law & Policy | Tagged: Malpractice Liability | Leave a comment »
On Crafting a Personal Financial Plan [A Fundamental Overview]
By Dr. David Edward Marcinko; MBA CMP™
Editor-in-Chief [Executive-Post]
For a review of financial planning and financial plan construction for physicians, and all medical professionals, please read this important white-paper:
Fundamentals of Financial Planning and Plan Construction for Physicians
Conclusion
And so, after review, is this a DIY project or is it time to call in a professional? Of course, execution and continuous monitoring is the next step.
Financial planning info: www.jbpub.com/catalog/0763745790/
Risk management info: www.jbpub.com/catalog/9780763733421/
Practice management info: www.springerpub.com/prod.aspx?prod_id=23759
Fiduciary Advisors: www.CertifiedMedicalPlanner.com
Institutional info: www.HealthcareFinancials.com
Additional terms: www.HealthDictionarySeries.com
Speaker: If you need a moderator or a speaker for an upcoming event, Dr. David Edward Marcinko; MBA – Editor and Publisher-in-Chief – is available for speaking engagements. Contact him at: MarcinkoAdvisors@msn.com
Filed under: Financial Planning | Tagged: Financial Planning | Leave a comment »
Understanding PSHPs
By Dr. David Edward Marcinko; MBA CMP™
[Publisher-in-Chief]
Capitation or Per Member / Per Month [PM/PM] fixed medical reimbursement models offer some of the same advantages to Point of Service Health Plans [PSHPs] as they do to HMOs. But, they are often more risky for the doctor or healthcare provider.
The main reason for the discrepancy is medical risk acceptance without considering the PSHP peculiarities.
For example, these plans, unlike HMOs, may allow out-of-network services and PSHP managers and providers must then pay the unmanaged outside contractors in addition to the discounted in-service physicians. This care therefore is an unknown future liability.
Of course, re-insurance is useful, but these plans tend to be chronically short of capital and, as a result, should expect higher operating costs than traditional HMOs.
Assessment
And so, what has been your experience with PSHPs; as either patient or provide?
Channel Surfing the ME-P
Have you visited our other topic channels? Established to facilitate idea exchange and link our community together, the value of these topics is dependent upon your input. Please take a minute to visit. And, to prevent that annoying spam, we ask that you register. It is fast, free and secure.
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
Filed under: Managed Care | Tagged: Managed Care | Leave a comment »
Different Structures – Varying Methods[By Lawrence E. Howes; CFP™]
[By Joel B. Javer; CFP™]
All medical practice and other business agreements that dictate what happens to a physician’s property should be addressed in what is called a buy-sell agreement.
Definition
A buy-sell agreement stipulates what would happen to your practice should you die, become disabled, leave, or wish to retire. The agreement states that your partner or partners will buy your interest upon your death and stipulates that your estate will sell your interest. It is a binding agreement to both parties.
The agreement will have a valuation method, which might be a stated fixed price, or a formula. If a fixed price is selected, then a procedure should be in place to assure at least an annual revaluation of the practice. Economic formulas provide a better ongoing representation of the value of the practice.
However, the dynamic healthcare environment might warrant a review of the validity of your existing formula. If the practice is valued highly – then having sufficient cash to buy out a deceased partner might be a difficult – and possibly an overwhelming financial burden.
Varying Buy-Sell Structures
Life insurance is commonly considered the best vehicle to provide the cash when it is needed the most, and there are a number of keys to creating a successful buy-sell agreement:
Varying Buy-Sell Model Forms
There are also a number of different forms of buy/sell agreements. The following is a quick overview of four different variations.
[1] Sole Proprietor Buy/Sell Agreement:
Since a sole medical proprietor does not have a partner, other than a spouse, they usually must look elsewhere for a buyer. Therefore, the sole proprietor is likely to turn either to a valued physician employee, a competitor to continue the business. In this case, a life insurance policy is purchased on the life of the proprietor, and the agreement is signed between the current and the future owners providing the guidelines for the future practice transfer. In addition to being the owner of the policy, the future doctor owner typically names him/herself beneficiary, as well.
[2] Cross Purchase Buy/Sell Agreement:
This type of buy/sell is normally used for any practice with multiple owners, although it is best used for agreements with only two owners. In this arrangement, each owner purchases insurance on each of the others lives. Again, the owner of each policy names him/herself beneficiary as well. Upon the death or disability of one partner, the remaining partner(s) are provided the funds to purchase a pro rata share of the deceased or disabled individual’s practice interest.
[3] Entity Purchase Buy/Sell Agreement:
This form is used for multiple owners, and/or when the owner(s) of the practice wants to use the assets of the business to fund the insurance policies. In this arrangement, the practice owns the policies on each partner or shareholder, and is also listed as the beneficiary of each policy. Upon the death or disability of the physician partner, the business would be able to purchase the shares from the disabled partner, or the deceased’s heirs.
[4] Optional Purchase/Wait and See Buy/Sell Agreement:
This type of agreement allows either the practice or the individual partner(s) the option of purchasing the deceased or disabled partner’s interest in the practice. Normally, if the practice does not initially exercise its option to buy within a set period, the remaining partner(s) would then have a period in which to exercise their option. If they do not buy the outstanding interest, the practice would then be forced to purchase the shares.
Assessment
Often, a trusteed agreement is advisable. It is not unusual to find situations where the practice partners work together smoothly and efficiently. Their spouses, however, are another story. So, in order to remove personalities from the transfer of ownership interests for money, especially at a very stressful point in their lives, it is often a good idea to let a disinterested third party (a trustee) conduct the transfer.
Example:
Dr. May has been the sole owner of The Family Physician Group, which includes six other physicians and twelve other employees, for over ten years. He has often thought about who will continue this successful practice. In the past month he has decided that Dr. Roy is the best candidate for the job. She has also expressed an interest in becoming the successor to Dr. May.
As a result, they have decided to set up a trusteed sole proprietor buy/sell agreement that would provide for the smooth, mandatory, transfer of the practice in the case of the death or disability of Dr. May. Once the practice is correctly valued, she plans to purchase a life insurance policy on the life of Dr. May, which will be owned by a third party trust, who will also be the beneficiary. Upon the death or disability of Dr. May, the agreement is executed by the trustee and Dr. Roy becomes sole owner of The Family Physician Group.
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
Filed under: Practice Worth | Leave a comment »
Understanding Different Trial Types
There are two types of malpractice trials available to doctors involved in litigation; by jury or a bench trial exclusively by the judge.
Jury Trial
In a trial by jury, the judge determines the law and the jury determines the facts.
Bench Trial
In a bench trial, the judge wears both the hats of being the trier of law, and the trier of fact. The U.S. Constitution guarantees a trial by jury. If a party does not request a jury trial that right may be deemed forfeit and by the same token, both sides must agree to waive a jury trial.
Which Trial Type is Best?
So, which trial type is best, and why would anyone choose to have a case heard by a judge as opposed to a jury, or vice versa? The reasons are mainly based on preconceived notions about judge and juror biases.
Generally, most litigants favor a jury over a judge because the decision is put into the hands of many rather than in the hands of one. Plaintiff patients usually like juries because lay individuals are believed to be more sympathetic, and a Plaintiff can appeal to the emotions of a jury.
Conversely, Defendant doctors usually prefer bench trials because a judge is thought to be more objective in deciding a case. Requesting a bench trial can also result in a much quicker trial date. Since court dockets in most large cities are becoming increasingly congested, the time difference between a jury trial date and a bench trial date can be literally years.
Assessment
None of the perceptions about the benefits of a jury trial or a bench trial apply to all situations—every case is different. And, there is at least some empirical evidence that some of the commonly held conceptions about bench and jury trials are actually misconceptions.
For example, while it is almost universally believed that juries tend to favor Plaintiffs and award much higher monetary amounts, a recent study by the Department of Justice suggests that judges favor Plaintiffs and return higher verdicts.
Still, jury trials outnumber bench trials by about two to one.
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
Filed under: Health Law & Policy | Tagged: Malpractice Liability | 2 Comments »
By Lawrence E. Howes; CFP™
By Joel B. Javer; CFP™
The Uniform Transfer to Minors Act (UTMA), or Uniform Gift to Minors Act (UGMA), provides for an account established by a checkmark on most mutual fund applications and/or brokerage accounts.
The account is primarily used by medical professionals as a tool for accumulating assets to pay for a child’s college education; however money may be used for most any purpose that benefits the child.
No trust documents have to be prepared. A uniform trust has been adopted by each state. A custodian, normally a physician-parent or grandparent is named as the party responsible for making investment decisions and distributing assets for the benefit of the child.
Example 1:
For example, reading classes, computer camp, ballet classes, etc. Money gifted to the trust qualifies under the annual gift tax exclusion [$12,000.00]. This money is a gift to the child and, depending upon state law, the child has control of it at age 18 or 21. The assets are removed from the physician donor’s estate, unless the giver dies while still the custodian of the account. In that case, the assets are taxed at the giver’s bracket until the child reaches age 14, at which time they are taxed directly to the child. Investments can be selected to minimize or eliminate taxation.
Example 2:
For example, individual stocks with no dividend might provide the appreciation without generating a taxable event until the stock is sold after the child reaches age 14. Alternatively, low turnover, growth-oriented, ETFs or tax-efficient mutual funds offer account growth with little or no taxable distributions.
Conclusion
What are the positives and negatives of UTMAs and UGMAs relative to college tuition; please comment?
More info: http://www.jbpub.com/catalog/0763745790/
Linguistics: www.HealthDictionarySeries.com
Filed under: Estate Planning | Tagged: Estate Planning | Leave a comment »
A Conceptual Review of Four Traditional Healthcare Models
By Dr. David E. Marcinko; MBA, CMP™
By Hope Rachel Hetico; RN, MHA, CMP™
In any discussion of theoretical competitive medical practice models – as a surrogate for more pragmatic real world competition – assumptions are made that include normal demand quantities, many fully informed patients, and the fact that physicians cannot directly influence demand for care (debatable).
These assumptions, although fluid, also negate that patient buyers are large enough have any influence over price.
Competitive Structures
A result of the above assumptions, four structures or models of competition emerge.
Conclusion
And so, what kind of competitive medical provider or physician executive are you; and is you competitive model based on locale, supply-demand, provider specialty or some other factors? Or, do these philosophical economic models offer any real world applications, at all?
Speaker: If you need a moderator or a speaker for an upcoming event, Dr. David Edward Marcinko; MBA – Editor and Publisher-in-Chief – is available for speaking engagements. Contact him at: MarcinkoAdvisors@msn.com
***
Filed under: Health Economics | Tagged: Health Economics | 1 Comment »
Good Health Policy or Competitive Anachronism?
By Staff Writers
Modern Healthcare just reported on a new study by an Alabama policy research group that questions whether the state needs to have a certificate of need process in place to limit the growth of healthcare facilities in the state.
The API Study
The study, by the Alabama Policy Institute [API], argued that the state’s CON regulations should be repealed. Its author, Roy Cordato, contended that if the state removes its CON restrictions, doctors, clinics and hospitals would be able to respond to competitive marketplace needs more quickly, which would actually improve the efficiency of healthcare delivery there.
Methodology
To conduct the study, researchers looked at the experience of other states with CON programs.
Assessment
It found that 13 states have recently repealed CON regulations. Removing CON requirements has given consumers improved access to care in those states. Meanwhile, there’s almost no evidence that Alabama’s existing CON process has helped to reduce healthcare costs.
Conclusion
And so, are CONs needed for competitive modernity, or are they relics of the misguided political past?
Related info: www.HealthCareFinancials.com
More info: The US Healthcare Certificate of Need Sourcebook
www.beardbooks.com/beardbooks/the_us_healthcare_certificate_of_need_sourcebook.html
Filed under: Health Law & Policy | Tagged: Health Law & Policy | 2 Comments »
By Dr. David E. Marcinko; MBA, CMP™
By Hope R. Hetico; RN, MHA, CMP™ 
With the recent popularity and growth of personal health insurance plans (PHIPs), health savings accounts (HSAs) and / or medical savings accounts (MSAs), compliance with the USA PATRIOT Act has become an important issue for these new health insurance products.
These insurance plans place financial services organizations into relationships with shared information institutions like hospitals, healthcare organizations, medical clinics and patient clients.
The Online Connection
This happens because many, perhaps even the majority of health insurance plans are opened online as patients and insurance company clients use Internet search engines to find the “best” policy type to meet their needs.
Appropriately, banks, healthcare entities, and hospitals are working with insurance companies, trust companies, banks and broker-dealers to offer identity-compliant and integrated insurance plan products.
Verifications that these clients are who they say they are, is as paramount as monitoring their activity.
Example:
Section 314(b) of the US Patriot Act permits financial institutions and health insurance companies – upon providing notice to the United States Department of the Treasury – to share patient and related information with one another in order to identify and report to the federal government activities that may involve money laundering or terrorist activity.
The US Patriot Act
The US Patriot Act aims to partially accomplish this through three critical goals:
Bank Secrecy Act, PHIPs, MSAs and HSAs
For additional compliance security, The USA Patriot Act also amended the Bank Secrecy Act [BSA] to give the federal government enhanced authority to identify, deter and punish money laundering and related terrorist financing activities.
Assessment
Whatever the financial outlays required for insurance/financial organizational compliance, it may result in very large savings later if affected hospital assets and patient health insurance information is safeguarded against attacks of virtual or real assets.
Conclusion
And so, what is your opinion on the above health law and policy?
Institutional information: www.HealthcareFinancials.com
Terminology: www.HealthDictionarySeries.com
Related reference: Marc B. Royo and David B. Nash. “Sarbanes-Oxley and Not-for-Profit Hospitals: Current Issues and Future Prospects.” American Journal of Medical Quality: Vol. 23, No. 1, 70-72, February 2008.
Filed under: Health Insurance, Practice Management, Risk Management | Tagged: Bank Secrecy Act, banks, david marcinko, hope hetico, hospitals, HSA, money laundering, MSA, Patriot Act, personal health insurance plans, PHIPs, Sarbanes, terrorist, trust companies, US Treasury Department, USTD | 1 Comment »
Many Different Assets May Trap Uninformed Doctors
By Lawrence E. Howes; CFP™
By Joel B. Javer; CFP™
There are situations where avoiding probate is desirable for physicians who want privacy for their finances after their death. And, there are relatively simple ways to avoid probate, but they all have consequences.
Several of these mechanisms are reviewed below:
Joint tenancy is the conventional way that property between spouses is titled. Each spouse maintains a 50 percent-undivided interest in the property. Upon death, the property automatically, by operation of law, passes to the surviving spouse and avoids probate. However, the automatic aspect of JT means that a will does not control the disposition of the asset. Before you title anything think about the consequences and be careful when establishing the ownership of all property.
Community property is another form of co-ownership limited to the interests held between husband and wife. Community property does not automatically pass to your spouse. When one spouse dies, the survivor continues to own only his or her half of the assets. The decedent’s will determines the transfer of the other half. Only eight of the 50 states are community-property states, but it is estimated that 25 percent of the population resides in these states. The eight states are Arizona, California, Idaho, Louisiana, Nevada, New Mexico, Texas, and Washington.
Wisconsin has a form of community property called “marital partnership property.” The laws of the particular state must be examined to determine the effect on the married couple’s property.
Life insurance is also property. The two aspects of the property are the face amount and unless it is a term life insurance policy, the cash value.
The critical item to remember is: if you own the policy, then the face amount or death benefit is included in your estate and probably subject to estate taxes. The death benefit passes through the operation of a beneficiary designation. At the time of death most cash value policies include the existing cash value in the death benefit. This is known as a type A policy. Type B excludes the cash value from the death benefit so it would be added to the face amount.
Your retirement plans and IRAs are transferred by beneficiary designation. It is common to see a physician who is divorced still have an ex-spouse as the named beneficiary on a retirement plan or life insurance policy. Making sure that all beneficiary designations are consistent with your current estate plan will avoid these unintended consequences.
In a revocable living trust your assets are voluntarily placed in a trust thereby making you a trustor. The control of the assets in the trust is then transferred to a trustee. You can make yourself the trustee as well.
The key word here is revocable, which means the terms of the trust can be changed, altered, amended or terminated. Legal title to the property however is retained by the trust. The trust can provide continuity of investment management, bill paying, collection of accounts receivable and general financial stability until the medical professional is able to resume control of his or her financial affairs.
In addition, if property is owned in more than one state, ownership of that property by a revocable living trust would eliminate the necessity of dealing with probate in several states.
[F] Buy-Sell Agreements
A highly valued medical practice may not have sufficient cash to buy out a deceased partner and face an overwhelming financial burden. Life insurance is commonly considered the best vehicle to provide the cash when it is needed the most, and there several different way to create a practice buy-sell agreement.
Nevertheless, always remember that it too, is an asset.
Conclusion:
What is your experience with any of the above non-probate assets in your estate planning endeavors?
More information: http://www.jbpub.com/catalog/9780763733421/
Linuistic terms: www.HealthDictionarySeries.com
Filed under: Estate Planning | Tagged: Estate Planning | 1 Comment »
The Connecticut State Challenge
The state of Connecticut has 31 hospitals that are economically struggling.
The Report
In fact, according to a 2006 report – led by Governor M. Jodi Rell – more than half of the state’s non-profit hospitals ran deficits while the rest generated below-adequate surpluses. Financial help has been slow from the state’s insurance programs.
The Findings
And so, the question raised by the state task force was whether these same hospitals should be paying CXOs steadily increasing salaries?
Examples:
Assessment
In their defense, the hospitals stated they must compete with national salary levels to recruit top talent. And so, what is your opinion on the matter; is there a dichotomy between medical-mission and personal profit-margin?
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
Filed under: Healthcare Finance | Tagged: Health Care Finance | 7 Comments »
“The Addictive Investing Personality of Medical Professionals and Related Compulsions”
An exclusive white-paper report on medical professionals and their investing compulsions by one of the nation’s leading psychologists, gambling addiction and trauma specialists.
AUTHORS:
Eugene Schmuckler PhD MBA MEd CTS [Behavioral Psychologist]
David Edward Marcinko CMP MBA MBBS
POSITION: Academic Dean: www.CertifiedMedicalPlanner.org an online certification program with fiduciary trademark logo that teaches financial professionals about contemporary health economics, physician focused financial planning, medical business management and related topics of organizational modernity.

http://www.CertifiedMedicalPlanner.org
TOPIC: The Addictive Investing Personality of Medical Professionals and Related Compulsions
EXERPT: “Hard-working physicians and other medical practitioners confronted with the problems associated with managed care and healthcare reform may very well choose to direct a portion of their energies to “playing the market.” It is legal and ethical and offers the opportunity of quickly increasing one’s personal wealth – or NOT.
Functioning virtually alone prevents others from questioning their actions. While not directly equivalent, this action is akin to the drinker who drinks alone so that no one really knows just how much is consumed – a recipe for financial and emotional disaster.”
Speaker: If you need a moderator or a speaker for an upcoming event, Dr. Gene Schmuckler is available for speaking engagements. Contact him at: MarcinkoAdvisors@msn.com
***
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
***
http://www.BusinessofMedicalPractice.com
***
Filed under: Monthly Reports | Tagged: Interviews and Special Reports | Leave a comment »
Doctors May Profit from Generic Drug Switch
Staff Writers
Several of the nation’s health plans are drawing scrutiny for offering financial incentives to entice doctors to prescribe cheaper generic medicines; according to a recent report from the Wall Street Journal.
This practice includes paying them up to $100 each time they switch a patient from a brand-name drug to a generic equivalent.
As some pharmaceutical patents for a growing number of blockbuster drugs expire, some health insurers are using doctor-bonuses for writing more generic prescriptions.
Proponents argue that the goal of saving patients, employers and insurers money is a noteworthy one. Others argue that it is only justified to reimburse doctors for spending time evaluating patients to determine whether a cheaper generic alternative is better – not for paying them for a wholesale switch.
But aggressive approaches, like cash-rewards for each patient switched from a given list of drugs, are coming under fire for injecting financial incentives into what should be a purely medical decision.
And, some medical societies are concerned that rewards may put doctors in the ethically questionable position of taking payments that patients know nothing about.
Conclusion: And so, what are your thoughts on the matter?
Lexicon: www.HealthDictionarySeries.com
Filed under: Drugs and Pharma | Tagged: Big Pharma and Drugs | 1 Comment »